Kurome® Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.Kurome Therapeutics is a preclinical stage company that is developing a series of IRAK1/4, panFLT3 inhibitors. Preclinical studies in the Starczynowski lab have demonstrated.Kurome® Therapeutics. All rights...
Kurome® Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.Kurome Therapeutics is a preclinical stage company that is developing a series of IRAK1/4, panFLT3 inhibitors. Preclinical studies in the Starczynowski lab have demonstrated.Kurome® Therapeutics. All rights reserved. Kurome is a registered trademark of Kurome Therapeutics.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.